Ronald J. Prentki
Gründer bei Easton Healthcare Ventures LLC
Profil
Ronald J.
Prentki is the founder of Easton Healthcare Ventures LLC, which was founded in 2005.
He currently holds the title of President at the company.
Mr. Prentki's former job positions include President & Chief Executive Officer at Heron Therapeutics, Inc. from 2008 to 2010, Director at Cardiovascular & Thoracic Surgeons of Greensboro PA, Manager-Anti Cancer Products at Bristol Myers Squibb Co. from 1985 to 1990, President at Progenics Pharmaceuticals, Inc. in 2005, VP-Business Development & Strategic Planning at Hoffmann-La Roche, Inc. in 1998, Vice President-Business Development at Sterling Drug, Inc. from 1990 to 1996, and Vice President-Business Development at Sanofi-Synthelabo, Inc. from 1990 to 1996.
Mr. Prentki's education history includes an undergraduate degree from Michigan State University and an MBA from the University of Detroit Mercy.
Aktive Positionen von Ronald J. Prentki
| Unternehmen | Position | Beginn |
|---|---|---|
| Easton Healthcare Ventures LLC | Gründer | 08.12.2009 |
Ehemalige bekannte Positionen von Ronald J. Prentki
| Unternehmen | Position | Ende |
|---|---|---|
| HERON THERAPEUTICS, INC. | Präsident | 26.05.2010 |
| PROGENICS PHARMACEUTICALS, INC. | Präsident | 01.01.2005 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.1998 |
| Sterling Drug, Inc. | Corporate Officer/Principal | 01.01.1996 |
| Sanofi-Synthelabo, Inc. | Corporate Officer/Principal | 01.01.1996 |
Ausbildung von Ronald J. Prentki
| Michigan State University | Undergraduate Degree |
| University of Detroit Mercy | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Sterling Drug, Inc. | Consumer Non-Durables |
| Sanofi-Synthelabo, Inc. | Health Technology |
| Cardiovascular & Thoracic Surgeons of Greensboro PA | |
| Easton Healthcare Ventures LLC |
